By MICHELLE CHAPMAN
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal.
The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre. U.S. regulators approved the inhaled medication more than a year ago to treat chronic obstructive pulmonary disease, or COPD, in adults.
“Ohtuvayre complements and expands our pipeline and portfolio of treatments for cardiopulmonary diseases while delivering near- and long-term growth as well as value for shareholders,” Merck & Co. Inc. Chairman and CEO Robert Davis said in a statement.
Verona CEO David Zaccardelli added that Merck’s commercial reach can help Ohtuvayre reach more COPD patients.
COPD is a progressive disease that can cause shortness of breath, coughing and other problems that make it hard to breathe, according to the National Institutes of Health. It is caused by damage to the airways or other parts of the lung and affects more than 14 million adults in the United States.
Ohtuvayre was launched last August as the first commercial product for London-based Verona Pharma. The drug also is being studied as a possible treatment for another chronic respiratory problem that gets worse over time: non-cystic fibrosis bronchiectasis.
Merck plans to pay $107 for each Verona Pharma American Depository Share, which represents eight of the company’s ordinary shares.
The deal announced Wednesday has been approved by the boards of both companies and is expected to close in the fourth quarter. But it still needs Verona Pharma shareholder approval and sanction by the High Court of Justice of England and Wales.
Shares of Rahway, New Jersey-based Merck climbed 25 cents to $81.63 before markets opened Wednesday.
AP Health Writer Tom Murphy contributed to this report.
Related Posts:
- Denise Richards Spends $25,000 Per Month on Food, According to Divorce Filing Entertainment <p id="par-1_12"><a href="https://www.cheatsheet.com/news/rhobh-denise-richards-named-worst-client-by-designers-pol-and-patrik-shes-just-not-the-nicest-person.html/">Denise Richards</a> is a big spender, according to her husband Aaron Phypers. </p> <p id="par-2_27">On Monday, Phypers filed to <a href="https://www.cheatsheet.com/tag/celebrity-relationships">end his marriage</a> to the Bravo star, whom he wed in 2018. His divorce petition exposes the details of the couple’s finances. </p> <p id="par-3_51">Richards, 54, earns $250,000 per month…
- The $1.3 Billion Utopia Of The Seas Is Royal Caribbean’s Big Bet On Short Cruises News (Royal Caribbean International) Cruising is now doing more with less. Royal Caribbean’s $1.3 billion gamble—the Utopia of the Seas—set sail last summer as a big bet: pack a full cruise experience into just three or four nights. It’s a risk when you consider weeklong trips are the global norm, so…
- Wimbledon star worth £3 billion plays on Centre Court today – but who is she? Sports Emma Navarro is hoping to reach the quarter-finals for the second year in a row today (Picture: Getty) American tennis player Emma Navarro, sitting on a £3 billion inheritance, faces Mirra Andreeva on Centre Court at Wimbledon 2025 today. The 24-year-old is set to become richer than Roger Federer, Rafael…
- Wimbledon star worth £3 billion plays on Centre Court today – but who is she? Sports Emma Navarro is hoping to reach the quarter-finals for the second year in a row today (Picture: Getty) American tennis player Emma Navarro, sitting on a £3 billion inheritance, faces Mirra Andreeva on Centre Court at Wimbledon 2025 today. The 24-year-old is set to become richer than Roger Federer, Rafael…
- Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed News By TOM MURPHY, AP Health Writer Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients. And even for people with…
(Visited 1 times, 1 visits today)